CSGP vs DMAAR · P/E 484, rev $1.82B vs $1.8M cap
CoStar Group Inc (CSGP) versus Drugs Made In America Acquisition Corp. Rights (DMAAR) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Drugs Made In America Acquisition Corp. Rights (DMAAR) common stock listed on US.
Latest reported CSGP revenue for 2026-06-30 was $1.82B. Net income was $58.0M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
DMAAR does not have a complete income-statement cache yet.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. DMAAR currently screens at market cap $1.8M.
Not investment advice. Open the CSGP and DMAAR stock pages for the full models.
Not investment advice.